Back to Search
Start Over
False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring ATM and CHEK2 Mutations.
- Source :
-
JCO Precision Oncology . 8/29/2024, Vol. 8, p1-3. 3p. - Publication Year :
- 2024
-
Abstract
- False-positive ctDNA results do not explain lack of efficacy for PARPi in patients with ATMm and CHEK2m CRPC. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 24734284
- Volume :
- 8
- Database :
- Academic Search Index
- Journal :
- JCO Precision Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 179339519
- Full Text :
- https://doi.org/10.1200/PO.24.00354